

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 5.41797029 |
| 2 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.07035102 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 4.79217845 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.79217845 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.69480114 |
| 6 | sulfur amino acid catabolic process (GO:0000098) | 4.68800693 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.66021662 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.66021662 |
| 9 | cysteine metabolic process (GO:0006534) | 4.56318217 |
| 10 | regulation of triglyceride catabolic process (GO:0010896) | 4.56283200 |
| 11 | serine family amino acid catabolic process (GO:0009071) | 4.48041407 |
| 12 | plasma lipoprotein particle clearance (GO:0034381) | 4.43690816 |
| 13 | regulation of sequestering of triglyceride (GO:0010889) | 4.35130378 |
| 14 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.34384504 |
| 15 | urea cycle (GO:0000050) | 4.25173420 |
| 16 | urea metabolic process (GO:0019627) | 4.25173420 |
| 17 | biotin metabolic process (GO:0006768) | 4.11349987 |
| 18 | valine metabolic process (GO:0006573) | 4.06557338 |
| 19 | aromatic amino acid family catabolic process (GO:0009074) | 4.06262395 |
| 20 | amino-acid betaine metabolic process (GO:0006577) | 4.05209621 |
| 21 | glyoxylate metabolic process (GO:0046487) | 3.98354661 |
| 22 | acylglycerol homeostasis (GO:0055090) | 3.95422651 |
| 23 | triglyceride homeostasis (GO:0070328) | 3.95422651 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 3.95119761 |
| 25 | triglyceride catabolic process (GO:0019433) | 3.93790909 |
| 26 | fatty acid beta-oxidation (GO:0006635) | 3.92833150 |
| 27 | glycine metabolic process (GO:0006544) | 3.90380333 |
| 28 | regulation of cholesterol storage (GO:0010885) | 3.89152580 |
| 29 | complement activation, alternative pathway (GO:0006957) | 3.88839440 |
| 30 | homocysteine metabolic process (GO:0050667) | 3.74353162 |
| 31 | serine family amino acid metabolic process (GO:0009069) | 3.74054614 |
| 32 | lysine metabolic process (GO:0006553) | 3.73543944 |
| 33 | lysine catabolic process (GO:0006554) | 3.73543944 |
| 34 | fatty acid oxidation (GO:0019395) | 3.70275256 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 3.67882133 |
| 36 | acylglycerol catabolic process (GO:0046464) | 3.67748807 |
| 37 | neutral lipid catabolic process (GO:0046461) | 3.67748807 |
| 38 | positive regulation of lipid catabolic process (GO:0050996) | 3.67423547 |
| 39 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.65610047 |
| 40 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.65206841 |
| 41 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.65206841 |
| 42 | fructose metabolic process (GO:0006000) | 3.62947824 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.62936296 |
| 44 | lipid oxidation (GO:0034440) | 3.62706268 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 3.60042058 |
| 46 | fatty acid catabolic process (GO:0009062) | 3.59433964 |
| 47 | negative regulation of fibrinolysis (GO:0051918) | 3.59089421 |
| 48 | tryptophan catabolic process (GO:0006569) | 3.57965130 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.57965130 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.57965130 |
| 51 | angiotensin maturation (GO:0002003) | 3.57906980 |
| 52 | kynurenine metabolic process (GO:0070189) | 3.53448297 |
| 53 | NADH metabolic process (GO:0006734) | 3.53183985 |
| 54 | pantothenate metabolic process (GO:0015939) | 3.50568700 |
| 55 | fatty acid transmembrane transport (GO:1902001) | 3.47550900 |
| 56 | bile acid biosynthetic process (GO:0006699) | 3.46612527 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 3.46465920 |
| 58 | branched-chain amino acid catabolic process (GO:0009083) | 3.46080098 |
| 59 | regulation of protein activation cascade (GO:2000257) | 3.44703981 |
| 60 | folic acid metabolic process (GO:0046655) | 3.43608169 |
| 61 | protein carboxylation (GO:0018214) | 3.41547289 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.41547289 |
| 63 | epoxygenase P450 pathway (GO:0019373) | 3.38327053 |
| 64 | carnitine metabolic process (GO:0009437) | 3.37213382 |
| 65 | tryptophan metabolic process (GO:0006568) | 3.34667694 |
| 66 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.34531472 |
| 67 | plasma lipoprotein particle remodeling (GO:0034369) | 3.34484056 |
| 68 | protein-lipid complex remodeling (GO:0034368) | 3.34484056 |
| 69 | macromolecular complex remodeling (GO:0034367) | 3.34484056 |
| 70 | branched-chain amino acid metabolic process (GO:0009081) | 3.34387251 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33959313 |
| 72 | positive regulation of fatty acid oxidation (GO:0046321) | 3.32505791 |
| 73 | triglyceride biosynthetic process (GO:0019432) | 3.32380555 |
| 74 | reverse cholesterol transport (GO:0043691) | 3.31483317 |
| 75 | phospholipid efflux (GO:0033700) | 3.31278326 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 3.31002747 |
| 77 | regulation of complement activation (GO:0030449) | 3.30581747 |
| 78 | folic acid transport (GO:0015884) | 3.27159762 |
| 79 | alpha-amino acid catabolic process (GO:1901606) | 3.27040402 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.23613598 |
| 81 | aromatic amino acid family metabolic process (GO:0009072) | 3.22529346 |
| 82 | acylglycerol biosynthetic process (GO:0046463) | 3.21467680 |
| 83 | neutral lipid biosynthetic process (GO:0046460) | 3.21467680 |
| 84 | monocarboxylic acid catabolic process (GO:0072329) | 3.21016432 |
| 85 | triglyceride metabolic process (GO:0006641) | 3.20571446 |
| 86 | bile acid metabolic process (GO:0008206) | 3.19031787 |
| 87 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.17879333 |
| 88 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.17852614 |
| 89 | cellular amino acid catabolic process (GO:0009063) | 3.15627270 |
| 90 | regulation of fibrinolysis (GO:0051917) | 3.15550518 |
| 91 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.14857875 |
| 92 | organic acid catabolic process (GO:0016054) | 3.12307815 |
| 93 | carboxylic acid catabolic process (GO:0046395) | 3.12307815 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.10684652 |
| 95 | diacylglycerol metabolic process (GO:0046339) | 3.10572117 |
| 96 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.10539811 |
| 97 | protein-lipid complex assembly (GO:0065005) | 3.09411972 |
| 98 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.08553831 |
| 99 | sterol homeostasis (GO:0055092) | 3.08047053 |
| 100 | urate metabolic process (GO:0046415) | 3.07480609 |
| 101 | negative regulation of sterol transport (GO:0032372) | 3.06515976 |
| 102 | negative regulation of cholesterol transport (GO:0032375) | 3.06515976 |
| 103 | phospholipid homeostasis (GO:0055091) | 3.05599834 |
| 104 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.04054315 |
| 105 | lipoprotein metabolic process (GO:0042157) | 3.03757489 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.02942226 |
| 107 | alditol metabolic process (GO:0019400) | 3.02290611 |
| 108 | acylglycerol metabolic process (GO:0006639) | 2.99880246 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.97571812 |
| 110 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.93952764 |
| 111 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.84837225 |
| 112 | oxaloacetate metabolic process (GO:0006107) | 2.84108153 |
| 113 | hormone catabolic process (GO:0042447) | 2.75280096 |
| 114 | cholesterol efflux (GO:0033344) | 2.73817790 |
| 115 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.71153787 |
| 116 | detection of bacterium (GO:0016045) | 2.70851309 |
| 117 | detection of other organism (GO:0098543) | 2.70558798 |
| 118 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.68201274 |
| 119 | negative regulation of cell killing (GO:0031342) | 2.68201274 |
| 120 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.65451690 |
| 121 | modulation by symbiont of host defense response (GO:0052031) | 2.61266598 |
| 122 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.61266598 |
| 123 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.61266598 |
| 124 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.61266598 |
| 125 | modulation by symbiont of host immune response (GO:0052553) | 2.61266598 |
| 126 | positive regulation by symbiont of host defense response (GO:0052509) | 2.61266598 |
| 127 | lipoprotein transport (GO:0042953) | 2.59877031 |
| 128 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.56149468 |
| 129 | drug metabolic process (GO:0017144) | 2.54585592 |
| 130 | plasma lipoprotein particle organization (GO:0071827) | 2.52120032 |
| 131 | protein-lipid complex subunit organization (GO:0071825) | 2.48706634 |
| 132 | macrophage activation involved in immune response (GO:0002281) | 2.48110100 |
| 133 | GDP-mannose metabolic process (GO:0019673) | 2.47925414 |
| 134 | detection of external biotic stimulus (GO:0098581) | 2.46469804 |
| 135 | peptide catabolic process (GO:0043171) | 2.45890812 |
| 136 | ethanol oxidation (GO:0006069) | 2.45852841 |
| 137 | creatine metabolic process (GO:0006600) | 2.42105570 |
| 138 | regulation of cellular extravasation (GO:0002691) | 2.41950958 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.41184802 |
| 140 | intestinal absorption (GO:0050892) | 2.37895177 |
| 141 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.37293899 |
| 142 | acute-phase response (GO:0006953) | 2.36905363 |
| 143 | sexual reproduction (GO:0019953) | 2.33477851 |
| 144 | detection of molecule of bacterial origin (GO:0032490) | 2.30108571 |
| 145 | regulation of sterol transport (GO:0032371) | 2.28471300 |
| 146 | regulation of cholesterol transport (GO:0032374) | 2.28471300 |
| 147 | regulation of triglyceride metabolic process (GO:0090207) | 2.27821480 |
| 148 | cell wall macromolecule catabolic process (GO:0016998) | 2.26846820 |
| 149 | cellular response to zinc ion (GO:0071294) | 2.24451225 |
| 150 | adhesion of symbiont to host (GO:0044406) | 2.23751316 |
| 151 | bile acid and bile salt transport (GO:0015721) | 2.20688277 |
| 152 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.19607096 |
| 153 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.18361607 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 2.17335411 |
| 155 | neutrophil activation involved in immune response (GO:0002283) | 2.17184348 |
| 156 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.15645801 |
| 157 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.15093018 |
| 158 | type I interferon signaling pathway (GO:0060337) | 2.12832645 |
| 159 | cellular response to type I interferon (GO:0071357) | 2.12832645 |
| 160 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.12410927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 7.31888763 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.43927946 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.80139216 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.44051754 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.61609216 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.58705855 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.48668830 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.34607821 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.29158993 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.88460706 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.64875046 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.44454530 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.38254643 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00606161 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92673077 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.89130937 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.87639594 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.81941767 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.79168661 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78622485 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.78610461 |
| 22 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.77902347 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76651511 |
| 24 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.74602024 |
| 25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.73284534 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71510712 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69598403 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.68463497 |
| 29 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62429682 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.59766203 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.59640848 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58708916 |
| 33 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.53810328 |
| 34 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53351164 |
| 35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.49215809 |
| 36 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45957008 |
| 37 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44005640 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42828697 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.41913417 |
| 40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41751145 |
| 41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40413022 |
| 42 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.40183047 |
| 43 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36152774 |
| 44 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36097404 |
| 45 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.35579621 |
| 46 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34456896 |
| 47 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.33351469 |
| 48 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33324502 |
| 49 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32430960 |
| 50 | P68_20966046_ChIP-Seq_HELA_Human | 1.32174953 |
| 51 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32002089 |
| 52 | SA1_27219007_Chip-Seq_Bcells_Human | 1.29247973 |
| 53 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.29198945 |
| 54 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.29125840 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.28056553 |
| 56 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26761843 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26442428 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25336529 |
| 59 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24537492 |
| 60 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24207805 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24131397 |
| 62 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.23428986 |
| 63 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23171938 |
| 64 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22749539 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.22580157 |
| 66 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20435703 |
| 67 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18603828 |
| 68 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18515921 |
| 69 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.18477220 |
| 70 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18469218 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.17305187 |
| 72 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16907423 |
| 73 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15679734 |
| 74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15621660 |
| 75 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14582821 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13949640 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13348944 |
| 78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12697094 |
| 79 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.12426087 |
| 80 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.11777779 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11337509 |
| 82 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11118733 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10953988 |
| 84 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10417541 |
| 85 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09682803 |
| 86 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.09143368 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07950711 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.07071379 |
| 89 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.06270377 |
| 90 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04345321 |
| 91 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.04120522 |
| 92 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03980013 |
| 93 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.03102632 |
| 94 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.02984274 |
| 95 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02443013 |
| 96 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02315771 |
| 97 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02096040 |
| 98 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02063811 |
| 99 | MAF_26560356_Chip-Seq_TH1_Human | 1.01763444 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01425855 |
| 101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01350045 |
| 102 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.01340426 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01265753 |
| 104 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.01262662 |
| 105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00966926 |
| 106 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98863128 |
| 107 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.98384617 |
| 108 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.97527105 |
| 109 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96920842 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96409485 |
| 111 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.95697592 |
| 112 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95353970 |
| 113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95292246 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95043725 |
| 115 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.94978172 |
| 116 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.94228121 |
| 117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.94201241 |
| 118 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.93680252 |
| 119 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.93494207 |
| 120 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93291267 |
| 121 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.92239004 |
| 122 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92152995 |
| 123 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.91635711 |
| 124 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91509040 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90143391 |
| 126 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.89986801 |
| 127 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.88814226 |
| 128 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.88496065 |
| 129 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88376665 |
| 130 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88111232 |
| 131 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87859289 |
| 132 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87291314 |
| 133 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.86211534 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86188938 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85866400 |
| 136 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85023813 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84560632 |
| 138 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.84423684 |
| 139 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.84098551 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83968903 |
| 141 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83776874 |
| 142 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83653291 |
| 143 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83048797 |
| 144 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.82978028 |
| 145 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.82950694 |
| 146 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.82615685 |
| 147 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.79837182 |
| 148 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.79115810 |
| 149 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78527530 |
| 150 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.78202409 |
| 151 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.77665000 |
| 152 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.77575113 |
| 153 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.76035676 |
| 154 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75930526 |
| 155 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.75818168 |
| 156 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.75616824 |
| 157 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.74036283 |
| 158 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73986520 |
| 159 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.72640438 |
| 160 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72301400 |
| 161 | P300_27268052_Chip-Seq_Bcells_Human | 0.72033545 |
| 162 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.71931848 |
| 163 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.71748128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.67989562 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.55221433 |
| 3 | MP0005365_abnormal_bile_salt | 4.41894190 |
| 4 | MP0005670_abnormal_white_adipose | 4.09907006 |
| 5 | MP0009840_abnormal_foam_cell | 3.96730944 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.78159257 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.39947074 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.08274480 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 2.90716898 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.90594211 |
| 11 | MP0005666_abnormal_adipose_tissue | 2.62756081 |
| 12 | MP0005332_abnormal_amino_acid | 2.52139633 |
| 13 | MP0004510_myositis | 2.46378920 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.23952902 |
| 15 | MP0003186_abnormal_redox_activity | 2.23092299 |
| 16 | MP0004019_abnormal_vitamin_homeostasis | 2.21516084 |
| 17 | MP0000609_abnormal_liver_physiology | 2.11697332 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.07166204 |
| 19 | MP0003303_peritoneal_inflammation | 2.00965564 |
| 20 | MP0003252_abnormal_bile_duct | 1.96934347 |
| 21 | MP0001666_abnormal_nutrient_absorption | 1.96332755 |
| 22 | MP0004185_abnormal_adipocyte_glucose | 1.93312917 |
| 23 | MP0008438_abnormal_cutaneous_collagen | 1.92548995 |
| 24 | MP0004130_abnormal_muscle_cell | 1.83962091 |
| 25 | MP0001764_abnormal_homeostasis | 1.81818960 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.77350072 |
| 27 | MP0005083_abnormal_biliary_tract | 1.67370399 |
| 28 | MP0002971_abnormal_brown_adipose | 1.66839520 |
| 29 | MP0002419_abnormal_innate_immunity | 1.64335868 |
| 30 | MP0005025_abnormal_response_to | 1.63855984 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.62957008 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.61688812 |
| 33 | MP0002876_abnormal_thyroid_physiology | 1.59123463 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.56696519 |
| 35 | MP0005451_abnormal_body_composition | 1.53992524 |
| 36 | MP0009115_abnormal_fat_cell | 1.53948006 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.47994862 |
| 38 | MP0005166_decreased_susceptibility_to | 1.44759902 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.44263590 |
| 40 | MP0003828_pulmonary_edema | 1.43649041 |
| 41 | MP0003075_altered_response_to | 1.38343216 |
| 42 | MP0002132_abnormal_respiratory_system | 1.38109859 |
| 43 | MP0003195_calcinosis | 1.38042356 |
| 44 | MP0005334_abnormal_fat_pad | 1.34513517 |
| 45 | MP0000685_abnormal_immune_system | 1.34050036 |
| 46 | MP0000751_myopathy | 1.33866690 |
| 47 | MP0001790_abnormal_immune_system | 1.33152420 |
| 48 | MP0005387_immune_system_phenotype | 1.33152420 |
| 49 | MP0000749_muscle_degeneration | 1.30528776 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.29843012 |
| 51 | MP0001661_extended_life_span | 1.24875686 |
| 52 | MP0000598_abnormal_liver_morphology | 1.22953583 |
| 53 | MP0001756_abnormal_urination | 1.21267464 |
| 54 | MP0005275_abnormal_skin_tensile | 1.19410503 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.19177834 |
| 56 | MP0003011_delayed_dark_adaptation | 1.19105672 |
| 57 | MP0003718_maternal_effect | 1.18267272 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.17687985 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17023328 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.16148847 |
| 61 | MP0002970_abnormal_white_adipose | 1.13980230 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.13615057 |
| 63 | MP0003329_amyloid_beta_deposits | 1.11765159 |
| 64 | MP0005330_cardiomyopathy | 1.11737701 |
| 65 | MP0005671_abnormal_response_to | 1.10477565 |
| 66 | MP0002723_abnormal_immune_serum | 1.10440779 |
| 67 | MP0002138_abnormal_hepatobiliary_system | 1.09508828 |
| 68 | MP0003693_abnormal_embryo_hatching | 1.07847072 |
| 69 | MP0002332_abnormal_exercise_endurance | 1.07551969 |
| 70 | MP0003866_abnormal_defecation | 1.05510680 |
| 71 | MP0004858_abnormal_nervous_system | 1.05045183 |
| 72 | MP0001800_abnormal_humoral_immune | 1.03826801 |
| 73 | MP0002254_reproductive_system_inflammat | 1.03113334 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.02299645 |
| 75 | MP0008004_abnormal_stomach_pH | 1.02278531 |
| 76 | MP0003436_decreased_susceptibility_to | 1.01944301 |
| 77 | MP0002452_abnormal_antigen_presenting | 0.98252606 |
| 78 | MP0005448_abnormal_energy_balance | 0.94778895 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 0.93287878 |
| 80 | MP0008469_abnormal_protein_level | 0.92822922 |
| 81 | MP0005165_increased_susceptibility_to | 0.92500341 |
| 82 | MP0005464_abnormal_platelet_physiology | 0.91648481 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.91529999 |
| 84 | MP0001819_abnormal_immune_cell | 0.90776642 |
| 85 | MP0002796_impaired_skin_barrier | 0.90142865 |
| 86 | MP0002420_abnormal_adaptive_immunity | 0.89864160 |
| 87 | MP0009763_increased_sensitivity_to | 0.89798015 |
| 88 | MP0000249_abnormal_blood_vessel | 0.88883855 |
| 89 | MP0003868_abnormal_feces_composition | 0.88255319 |
| 90 | MP0003879_abnormal_hair_cell | 0.88118881 |
| 91 | MP0004947_skin_inflammation | 0.86516821 |
| 92 | MP0006138_congestive_heart_failure | 0.86029856 |
| 93 | MP0001881_abnormal_mammary_gland | 0.85706282 |
| 94 | MP0002136_abnormal_kidney_physiology | 0.84945060 |
| 95 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84146124 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.83426419 |
| 97 | MP0005023_abnormal_wound_healing | 0.83240889 |
| 98 | MP0000604_amyloidosis | 0.83218678 |
| 99 | MP0005395_other_phenotype | 0.83097344 |
| 100 | MP0009764_decreased_sensitivity_to | 0.82769916 |
| 101 | MP0005535_abnormal_body_temperature | 0.80567556 |
| 102 | MP0005376_homeostasis/metabolism_phenot | 0.80532248 |
| 103 | MP0009697_abnormal_copulation | 0.79950093 |
| 104 | MP0003279_aneurysm | 0.79780984 |
| 105 | MP0002078_abnormal_glucose_homeostasis | 0.79414311 |
| 106 | MP0003724_increased_susceptibility_to | 0.77747813 |
| 107 | MP0009642_abnormal_blood_homeostasis | 0.77583487 |
| 108 | MP0002933_joint_inflammation | 0.77109737 |
| 109 | MP0000747_muscle_weakness | 0.74619693 |
| 110 | MP0002837_dystrophic_cardiac_calcinosis | 0.74618372 |
| 111 | MP0000858_altered_metastatic_potential | 0.74488209 |
| 112 | MP0004264_abnormal_extraembryonic_tissu | 0.74035798 |
| 113 | MP0005636_abnormal_mineral_homeostasis | 0.73900588 |
| 114 | MP0004883_abnormal_blood_vessel | 0.73290783 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.72157764 |
| 116 | MP0003690_abnormal_glial_cell | 0.72146744 |
| 117 | MP0002060_abnormal_skin_morphology | 0.69851636 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.67977057 |
| 119 | MP0001853_heart_inflammation | 0.67646333 |
| 120 | MP0003959_abnormal_lean_body | 0.66568361 |
| 121 | MP0000343_altered_response_to | 0.66428539 |
| 122 | MP0004782_abnormal_surfactant_physiolog | 0.64834061 |
| 123 | MP0005647_abnormal_sex_gland | 0.64643048 |
| 124 | MP0008260_abnormal_autophagy | 0.64298168 |
| 125 | MP0005266_abnormal_metabolism | 0.64039108 |
| 126 | MP0000750_abnormal_muscle_regeneration | 0.63943281 |
| 127 | MP0006035_abnormal_mitochondrial_morpho | 0.63906652 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.62778795 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.62778795 |
| 130 | MP0001542_abnormal_bone_strength | 0.62639604 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.62439395 |
| 132 | MP0006082_CNS_inflammation | 0.61989224 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.61284055 |
| 134 | MP0000013_abnormal_adipose_tissue | 0.60733091 |
| 135 | MP0010352_gastrointestinal_tract_polyps | 0.60321861 |
| 136 | MP0005164_abnormal_response_to | 0.58390186 |
| 137 | MP0000358_abnormal_cell_content/ | 0.58360531 |
| 138 | MP0005410_abnormal_fertilization | 0.57454320 |
| 139 | MP0009053_abnormal_anal_canal | 0.57444917 |
| 140 | MP0000003_abnormal_adipose_tissue | 0.56446029 |
| 141 | MP0009785_altered_susceptibility_to | 0.52933949 |
| 142 | MP0004957_abnormal_blastocyst_morpholog | 0.52158106 |
| 143 | MP0005452_abnormal_adipose_tissue | 0.51871158 |
| 144 | MP0001845_abnormal_inflammatory_respons | 0.50832627 |
| 145 | MP0009672_abnormal_birth_weight | 0.50567543 |
| 146 | MP0003646_muscle_fatigue | 0.49590372 |
| 147 | MP0002135_abnormal_kidney_morphology | 0.47989931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperglycinuria (HP:0003108) | 5.74260046 |
| 2 | Xanthomatosis (HP:0000991) | 5.14326112 |
| 3 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.98728431 |
| 4 | Abnormality of glycine metabolism (HP:0010895) | 4.98728431 |
| 5 | Hyperglycinemia (HP:0002154) | 4.85664903 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.49784661 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 4.46624030 |
| 8 | Hyperammonemia (HP:0001987) | 4.33568228 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.32902850 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.28308240 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.19222389 |
| 12 | Deep venous thrombosis (HP:0002625) | 4.12956511 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.08380184 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 4.05671300 |
| 15 | Complement deficiency (HP:0004431) | 4.02501966 |
| 16 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.01182938 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.80692899 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.75326262 |
| 19 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.62880997 |
| 20 | Hypertriglyceridemia (HP:0002155) | 3.49807768 |
| 21 | Ketosis (HP:0001946) | 3.47740171 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.42552682 |
| 23 | Abnormality of serum amino acid levels (HP:0003112) | 3.41871621 |
| 24 | Oligomenorrhea (HP:0000876) | 3.37980404 |
| 25 | Abnormality of macrophages (HP:0004311) | 3.37653011 |
| 26 | Epidermoid cyst (HP:0200040) | 3.35570252 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 3.28883040 |
| 28 | Nausea (HP:0002018) | 3.28195901 |
| 29 | Dicarboxylic aciduria (HP:0003215) | 3.23606449 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.23606449 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 3.17767428 |
| 32 | Myocardial infarction (HP:0001658) | 3.16691887 |
| 33 | Abnormality of complement system (HP:0005339) | 3.15903479 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.14360683 |
| 35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.13920089 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 3.10615049 |
| 37 | Hydroxyprolinuria (HP:0003080) | 3.10615049 |
| 38 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.08079168 |
| 39 | Gout (HP:0001997) | 2.96919112 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 2.96854138 |
| 41 | Hypercholesterolemia (HP:0003124) | 2.95968254 |
| 42 | Multiple enchondromatosis (HP:0005701) | 2.95242556 |
| 43 | Lethargy (HP:0001254) | 2.94737640 |
| 44 | Amyloidosis (HP:0011034) | 2.92678798 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.90567023 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.90374089 |
| 47 | Abnormal cartilage morphology (HP:0002763) | 2.84794051 |
| 48 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.77992791 |
| 49 | Acanthosis nigricans (HP:0000956) | 2.76033104 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.70157809 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.68818179 |
| 52 | Ileus (HP:0002595) | 2.65794617 |
| 53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.63413304 |
| 54 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.59223439 |
| 55 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.59223439 |
| 56 | Abnormality of glycolipid metabolism (HP:0010969) | 2.59223439 |
| 57 | Abnormality of methionine metabolism (HP:0010901) | 2.53403987 |
| 58 | Proximal tubulopathy (HP:0000114) | 2.51161630 |
| 59 | Fat malabsorption (HP:0002630) | 2.50373256 |
| 60 | Ketoacidosis (HP:0001993) | 2.48053803 |
| 61 | Increased purine levels (HP:0004368) | 2.46187894 |
| 62 | Hyperuricemia (HP:0002149) | 2.46187894 |
| 63 | Dysostosis multiplex (HP:0000943) | 2.45512394 |
| 64 | Joint hemorrhage (HP:0005261) | 2.44573376 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.44388792 |
| 66 | Abnormality of the intrinsic pathway (HP:0010989) | 2.43808157 |
| 67 | Pancreatitis (HP:0001733) | 2.43557710 |
| 68 | Metabolic acidosis (HP:0001942) | 2.43525098 |
| 69 | Malnutrition (HP:0004395) | 2.42957193 |
| 70 | Cholecystitis (HP:0001082) | 2.39716754 |
| 71 | Abnormal gallbladder physiology (HP:0012438) | 2.39716754 |
| 72 | Rhabdomyolysis (HP:0003201) | 2.36422671 |
| 73 | Orchitis (HP:0100796) | 2.35709050 |
| 74 | Generalized aminoaciduria (HP:0002909) | 2.33476919 |
| 75 | Myopathic facies (HP:0002058) | 2.32863651 |
| 76 | Myositis (HP:0100614) | 2.32456145 |
| 77 | Bulbar palsy (HP:0001283) | 2.31939108 |
| 78 | Skin nodule (HP:0200036) | 2.31621195 |
| 79 | Recurrent bacterial skin infections (HP:0005406) | 2.24151739 |
| 80 | Vacuolated lymphocytes (HP:0001922) | 2.24116164 |
| 81 | Axonal loss (HP:0003447) | 2.22844574 |
| 82 | Petechiae (HP:0000967) | 2.22177343 |
| 83 | Brushfield spots (HP:0001088) | 2.18675303 |
| 84 | Vomiting (HP:0002013) | 2.18269438 |
| 85 | Purpura (HP:0000979) | 2.15731841 |
| 86 | Vertebral compression fractures (HP:0002953) | 2.15347662 |
| 87 | Muscle fiber splitting (HP:0003555) | 2.14344331 |
| 88 | Cerebral edema (HP:0002181) | 2.11112849 |
| 89 | Irritability (HP:0000737) | 2.11086765 |
| 90 | Hemorrhage of the eye (HP:0011885) | 2.08955388 |
| 91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08611443 |
| 92 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08611443 |
| 93 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08611443 |
| 94 | Exercise-induced myalgia (HP:0003738) | 2.08192983 |
| 95 | Insulin resistance (HP:0000855) | 2.07276862 |
| 96 | Increased connective tissue (HP:0009025) | 2.07156157 |
| 97 | Obstructive lung disease (HP:0006536) | 2.02034831 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.02034831 |
| 99 | Mucopolysacchariduria (HP:0008155) | 2.00931516 |
| 100 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00931516 |
| 101 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00161198 |
| 102 | Gingivitis (HP:0000230) | 1.99763759 |
| 103 | Increased serum ferritin (HP:0003281) | 1.99364913 |
| 104 | Gingival bleeding (HP:0000225) | 1.98412157 |
| 105 | Growth hormone excess (HP:0000845) | 1.98348501 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 1.97718501 |
| 107 | Delayed CNS myelination (HP:0002188) | 1.97057383 |
| 108 | Long foot (HP:0001833) | 1.96694704 |
| 109 | Joint swelling (HP:0001386) | 1.96611407 |
| 110 | Upper motor neuron abnormality (HP:0002127) | 1.95620730 |
| 111 | Increased muscle lipid content (HP:0009058) | 1.95285862 |
| 112 | Hyporeflexia of lower limbs (HP:0002600) | 1.94464669 |
| 113 | Loss of speech (HP:0002371) | 1.92718388 |
| 114 | Widely patent fontanelles and sutures (HP:0004492) | 1.91888199 |
| 115 | Spastic diplegia (HP:0001264) | 1.90252867 |
| 116 | Hyperglycemia (HP:0003074) | 1.89394891 |
| 117 | Progressive neurologic deterioration (HP:0002344) | 1.88214119 |
| 118 | Premature rupture of membranes (HP:0001788) | 1.88066216 |
| 119 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86682336 |
| 120 | Myoglobinuria (HP:0002913) | 1.86561627 |
| 121 | Vascular calcification (HP:0004934) | 1.86130904 |
| 122 | Steatorrhea (HP:0002570) | 1.86077345 |
| 123 | Autoimmune thrombocytopenia (HP:0001973) | 1.85567309 |
| 124 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.84734769 |
| 125 | Nephritis (HP:0000123) | 1.84629602 |
| 126 | Hypophosphatemia (HP:0002148) | 1.84625032 |
| 127 | Abnormality of glycolysis (HP:0004366) | 1.84484714 |
| 128 | Increased serum pyruvate (HP:0003542) | 1.84484714 |
| 129 | Opisthotonus (HP:0002179) | 1.83358938 |
| 130 | Global brain atrophy (HP:0002283) | 1.82810330 |
| 131 | Esophageal varix (HP:0002040) | 1.82263824 |
| 132 | Megaloblastic anemia (HP:0001889) | 1.81898121 |
| 133 | Optic neuritis (HP:0100653) | 1.81566542 |
| 134 | Retrobulbar optic neuritis (HP:0100654) | 1.81566542 |
| 135 | Glomerulonephritis (HP:0000099) | 1.80698764 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 1.80613822 |
| 137 | Type 1 muscle fiber predominance (HP:0003803) | 1.79961334 |
| 138 | Polycythemia (HP:0001901) | 1.79851144 |
| 139 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79575880 |
| 140 | Glycosuria (HP:0003076) | 1.79271933 |
| 141 | Abnormality of urine glucose concentration (HP:0011016) | 1.79271933 |
| 142 | Hepatocellular carcinoma (HP:0001402) | 1.78419365 |
| 143 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.78404417 |
| 144 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78048695 |
| 145 | Hyperbilirubinemia (HP:0002904) | 1.77093722 |
| 146 | Cardiovascular calcification (HP:0011915) | 1.76511004 |
| 147 | Cerebral palsy (HP:0100021) | 1.76249349 |
| 148 | Sensorimotor neuropathy (HP:0007141) | 1.76226546 |
| 149 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.75828729 |
| 150 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75178640 |
| 151 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74991451 |
| 152 | Ventricular tachycardia (HP:0004756) | 1.74891348 |
| 153 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74433432 |
| 154 | Methylmalonic aciduria (HP:0012120) | 1.74230842 |
| 155 | Hepatosplenomegaly (HP:0001433) | 1.74120368 |
| 156 | Muscle fibrillation (HP:0010546) | 1.73967910 |
| 157 | Spontaneous abortion (HP:0005268) | 1.73761749 |
| 158 | CNS demyelination (HP:0007305) | 1.72893741 |
| 159 | Sudden death (HP:0001699) | 1.72829274 |
| 160 | Stomatitis (HP:0010280) | 1.72267668 |
| 161 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71825527 |
| 162 | Episodic fever (HP:0001954) | 1.71756003 |
| 163 | EMG: myopathic abnormalities (HP:0003458) | 1.70016982 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.06032998 |
| 2 | TRIB3 | 3.96612938 |
| 3 | ERN1 | 3.46047323 |
| 4 | PDK4 | 3.17307814 |
| 5 | PDK3 | 3.17307814 |
| 6 | BUB1 | 2.85027230 |
| 7 | TXK | 2.77857912 |
| 8 | NME2 | 2.67343216 |
| 9 | RIPK4 | 2.66998223 |
| 10 | SIK1 | 2.48993063 |
| 11 | EPHA2 | 2.34923744 |
| 12 | TESK1 | 2.34479534 |
| 13 | PDK2 | 2.21601694 |
| 14 | PRPF4B | 2.10807163 |
| 15 | TESK2 | 2.10466744 |
| 16 | EPHB1 | 2.08634482 |
| 17 | CAMK1D | 1.98448455 |
| 18 | EIF2AK1 | 1.89437449 |
| 19 | FGFR4 | 1.86404102 |
| 20 | MST1R | 1.75281420 |
| 21 | LATS2 | 1.71180912 |
| 22 | MAP3K3 | 1.63448328 |
| 23 | STK38L | 1.57302256 |
| 24 | ABL2 | 1.56275982 |
| 25 | GRK7 | 1.52790641 |
| 26 | PIM2 | 1.52604447 |
| 27 | MUSK | 1.52134047 |
| 28 | MAP4K1 | 1.50200612 |
| 29 | KDR | 1.50097609 |
| 30 | CSK | 1.46259375 |
| 31 | MAP3K12 | 1.45915364 |
| 32 | IRAK3 | 1.44878358 |
| 33 | MAP3K11 | 1.39958497 |
| 34 | IRAK4 | 1.39076472 |
| 35 | RPS6KA4 | 1.33469744 |
| 36 | NEK9 | 1.32873153 |
| 37 | NEK1 | 1.31376595 |
| 38 | NEK2 | 1.30275651 |
| 39 | MAP2K3 | 1.28512301 |
| 40 | WEE1 | 1.24126154 |
| 41 | TTN | 1.22931767 |
| 42 | MAP3K1 | 1.07929259 |
| 43 | TNK2 | 1.02334504 |
| 44 | PRKD2 | 1.02003776 |
| 45 | TYK2 | 1.01417700 |
| 46 | TTK | 0.99420973 |
| 47 | TBK1 | 0.97994678 |
| 48 | MAPK11 | 0.97662326 |
| 49 | TAOK2 | 0.96162456 |
| 50 | PKN2 | 0.95409541 |
| 51 | SIK3 | 0.94461074 |
| 52 | PDK1 | 0.94223396 |
| 53 | BRSK2 | 0.92473165 |
| 54 | LATS1 | 0.91146783 |
| 55 | BRAF | 0.91002464 |
| 56 | ERBB4 | 0.90903327 |
| 57 | AKT3 | 0.89988313 |
| 58 | MAPK12 | 0.88748744 |
| 59 | CDK4 | 0.87560890 |
| 60 | DYRK3 | 0.86388055 |
| 61 | PLK4 | 0.86124927 |
| 62 | JAK2 | 0.85636527 |
| 63 | PAK4 | 0.85219318 |
| 64 | EPHA3 | 0.84031468 |
| 65 | GRK5 | 0.83033974 |
| 66 | MAP2K2 | 0.82934945 |
| 67 | IKBKE | 0.82689350 |
| 68 | STK3 | 0.81726183 |
| 69 | CDK6 | 0.81230783 |
| 70 | MAP2K1 | 0.80944247 |
| 71 | SCYL2 | 0.80592651 |
| 72 | ARAF | 0.79848087 |
| 73 | MAP3K8 | 0.78170823 |
| 74 | MATK | 0.77489133 |
| 75 | JAK1 | 0.76770201 |
| 76 | KSR2 | 0.76457120 |
| 77 | OBSCN | 0.75235910 |
| 78 | ACVR1B | 0.74975707 |
| 79 | CDC42BPA | 0.73987475 |
| 80 | STK16 | 0.72345475 |
| 81 | MAP3K10 | 0.72323129 |
| 82 | JAK3 | 0.70854565 |
| 83 | DYRK2 | 0.70659732 |
| 84 | PRKD1 | 0.70022850 |
| 85 | DMPK | 0.69063026 |
| 86 | FRK | 0.68252599 |
| 87 | PIK3CG | 0.67790182 |
| 88 | GRK6 | 0.67751023 |
| 89 | SIK2 | 0.67710761 |
| 90 | STK38 | 0.66865708 |
| 91 | MAP3K5 | 0.65593417 |
| 92 | FES | 0.63763320 |
| 93 | TAOK1 | 0.63292348 |
| 94 | PIM1 | 0.62693887 |
| 95 | PRKAA2 | 0.61837633 |
| 96 | TGFBR2 | 0.59159000 |
| 97 | LRRK2 | 0.58691572 |
| 98 | PAK1 | 0.57748486 |
| 99 | PINK1 | 0.56826371 |
| 100 | MAP3K6 | 0.56603603 |
| 101 | DDR2 | 0.56033547 |
| 102 | ZAP70 | 0.55856390 |
| 103 | EPHB2 | 0.55453678 |
| 104 | PLK1 | 0.55122576 |
| 105 | FGR | 0.53681149 |
| 106 | PRKAA1 | 0.52694913 |
| 107 | SYK | 0.52612235 |
| 108 | BLK | 0.52056882 |
| 109 | MTOR | 0.51266803 |
| 110 | DYRK1B | 0.51037771 |
| 111 | EIF2AK3 | 0.50943452 |
| 112 | MAPKAPK3 | 0.50084051 |
| 113 | EIF2AK2 | 0.49212231 |
| 114 | CAMK1G | 0.48887764 |
| 115 | HCK | 0.47559082 |
| 116 | PRKD3 | 0.47232396 |
| 117 | STK10 | 0.46740033 |
| 118 | LYN | 0.46657756 |
| 119 | AURKA | 0.46007582 |
| 120 | RIPK1 | 0.45890801 |
| 121 | GSK3A | 0.45869250 |
| 122 | PRKG2 | 0.45732091 |
| 123 | DAPK3 | 0.45555238 |
| 124 | MAPKAPK2 | 0.45172910 |
| 125 | ILK | 0.44455728 |
| 126 | LIMK1 | 0.44238091 |
| 127 | PDPK1 | 0.43996144 |
| 128 | IRAK2 | 0.43881015 |
| 129 | PHKG1 | 0.43852214 |
| 130 | PHKG2 | 0.43852214 |
| 131 | MET | 0.43442442 |
| 132 | MAPK4 | 0.42972780 |
| 133 | SMG1 | 0.42238043 |
| 134 | FYN | 0.42184058 |
| 135 | PAK2 | 0.41788775 |
| 136 | ICK | 0.41759290 |
| 137 | PTK6 | 0.41584078 |
| 138 | MOS | 0.40178444 |
| 139 | PTK2 | 0.39817918 |
| 140 | PRKCZ | 0.38953027 |
| 141 | BMX | 0.38412189 |
| 142 | LMTK2 | 0.38213913 |
| 143 | DAPK2 | 0.37515151 |
| 144 | MAP2K6 | 0.37347658 |
| 145 | IKBKB | 0.36812249 |
| 146 | PRKACG | 0.35278931 |
| 147 | AURKB | 0.33888233 |
| 148 | BRSK1 | 0.31889318 |
| 149 | MYLK | 0.31498203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.98231352 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.86229610 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.68223422 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.66563023 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61678225 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.60444460 |
| 7 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.47123314 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.42620176 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41491746 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.35413463 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.25944569 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25175216 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.16462164 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.06822651 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.03132914 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 1.97647182 |
| 17 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97069996 |
| 18 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.93307515 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.91951351 |
| 20 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.89078123 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.88969123 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84875600 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.82958907 |
| 24 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80753834 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76850169 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76419047 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.76324768 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.75669732 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71621456 |
| 30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.70524447 |
| 31 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.59736701 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.58913207 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.56660350 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.54981074 |
| 35 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.51619584 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46454856 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.42951728 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.42607252 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42241988 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.41158561 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.37291927 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.36602662 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.32999311 |
| 44 | Proteasome_Homo sapiens_hsa03050 | 1.30349185 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22922472 |
| 46 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.19689613 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14295190 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.14032049 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.13101630 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 1.09867768 |
| 51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09668643 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08091604 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06176808 |
| 54 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.05624498 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05559644 |
| 56 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02550740 |
| 57 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01841892 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00872240 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99215063 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98601482 |
| 61 | Pertussis_Homo sapiens_hsa05133 | 0.96004581 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94200471 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87463454 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.87180879 |
| 65 | Allograft rejection_Homo sapiens_hsa05330 | 0.83611265 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80575995 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78848455 |
| 68 | Bile secretion_Homo sapiens_hsa04976 | 0.75501688 |
| 69 | Viral myocarditis_Homo sapiens_hsa05416 | 0.73946787 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73564017 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73190851 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70676926 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69332508 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69284334 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.68650988 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.66129573 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66058919 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.64474445 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64137805 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63983681 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61068023 |
| 82 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60434321 |
| 83 | Phagosome_Homo sapiens_hsa04145 | 0.60273894 |
| 84 | Tuberculosis_Homo sapiens_hsa05152 | 0.60254950 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.59245922 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55839626 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.54536623 |
| 88 | Salmonella infection_Homo sapiens_hsa05132 | 0.54119701 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53129712 |
| 90 | Malaria_Homo sapiens_hsa05144 | 0.52369908 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52357323 |
| 92 | ABC transporters_Homo sapiens_hsa02010 | 0.50937172 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.50901713 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50622587 |
| 95 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.48458151 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.47604081 |
| 97 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.47201934 |
| 98 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47182685 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46294499 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44886320 |
| 101 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.44088040 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43629750 |
| 103 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43189108 |
| 104 | Hepatitis C_Homo sapiens_hsa05160 | 0.42535560 |
| 105 | RNA polymerase_Homo sapiens_hsa03020 | 0.42355768 |
| 106 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41553593 |
| 107 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40454586 |
| 108 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40446662 |
| 109 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.38982096 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37762224 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.37582245 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.36213931 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.32454789 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.32180121 |
| 115 | Lysine degradation_Homo sapiens_hsa00310 | 0.29931517 |
| 116 | RNA transport_Homo sapiens_hsa03013 | 0.28589791 |
| 117 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25867696 |
| 118 | Lysosome_Homo sapiens_hsa04142 | 0.24737923 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.24497906 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.20618829 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.19727930 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.17911366 |
| 123 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15670790 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.14957027 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.12898313 |
| 126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08093709 |
| 127 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.07866133 |
| 128 | Purine metabolism_Homo sapiens_hsa00230 | 0.07553099 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.07227794 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.07150463 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.06881224 |
| 132 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.04509751 |

